|
⚲
|
| Keyboard |
| Spruce Street Capital LP
✚
|
|
|---|---|
| CRD # | 333213 |
| SEC # | 801-132577 |
| CIK # | 0002050194 |
| AUM | 555.9 M (2026-03-02) |
| Employees | 4 (75% Investors, 0% Brokers) |
| Phone | 646-416-9712 |
| Address | 777 Third Avenue New York, NY 10017 |
| Source | [IAPD] [EDGAR] [LinkedIn] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Camp Nine Inc | 43.0 | ||
| Kiniksa Pharmaceuticals Ltd | 36.6 | ||
| LB Pharmaceuticals Inc | 33.6 | ||
| Magenta Therapeutics Inc | 31.3 | ||
| Relay Therapeutics Inc | 29.7 | ||
| Alto Neuroscience Inc | 29.1 | ||
| Adventrx Pharmaceuticals Inc | 18.5 | ||
| Vaxcyte Inc | 14.3 | ||
| Imara Inc | 12.9 | ||
| Consonance-HFW Acquisition Corp | 12.6 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Spruce Street Capital Master Fund LP | 2025-03-28 | 458.3 M | |
| HF | Spruce Street Capital Offshore Fund LP | [2025-03-28] | 152.6 M | 338.9 M |
| Filed 2025-10-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Spruce Street Capital Onshore Fund LP | [2025-03-28] | 47.7 M | 103.7 M |
| Filed 2025-10-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 555.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 4 | 555.9 |
| By Discretionary | ||
| Discretionary | 4 | 555.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 555.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 452.1 | |
| United States Persons | 103.8 | |
| Total | 4 | 555.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Alex Rosen | Executive Officer | 7 | 2 | |
| Simon Basseyn | Executive Officer | 3 | 2 | |
| Spruce Street Capital Fund GP LLC | Executive Officer | 2 | 1 | |
| Spruce Street Capital LP | Promoter | 2 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002050194] | |
| SC 13G | [0002050194] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Spruce Street Capital LP | Relmada Therapeutics Inc | [2026-02-17] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 2549001ICA4Q5ZPPGF12 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Pier 88 Investment Partners LLC
✚
|
CA | 568.0 M |
|
Rhino Investment Partners Inc
✚
|
PA | 566.2 M |
|
Stieven Capital Advisors LP
✚
|
MO | 563.4 M |
|
Harraden Circle Investments LLC
✚
|
NY | 562.9 M |
|
Canaras Capital Management LLC
✚
|
NY | 561.0 M |
|
Qvidtvm Management LLC
✚
|
TX | 555.8 M |
|
Avalon Global Asset Management LLC
✚
|
CA | 553.8 M |
|
Northern Right Capital Management LP
✚
|
CT | 552.8 M |
|
Exome Asset Management LLC
✚
|
NY | 548.6 M |
|
TSW II Capital Advisors LLC
✚
|
TN | 544.5 M |